Searched for
BHARAT BIOTECH
'Only Covaxin to be administered to 15-18 age group': Bharat Biotech asks health workers to be 'vigilant'08 Jan, 2022, 10.40 AM IST
Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM IST
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech17 Jun, 2022, 12.15 PM IST
COVID-19 vaccine: India aims to release indigenous 'Covaxin' by August 15, 2020; ICMR ramps up efforts03 Jul, 2020, 01.25 PM IST
Bharat Biotech's Nasal Vaccine available as booster dose on CoWIN App starting today23 Dec, 2022, 05.34 PM IST
Covaxin likely to be available in first quarter of 2021: Bharat Biotech10 Dec, 2020, 08.21 AM IST
After Covishield, Covaxin price slashed, Bharat Biotech to sell vaccine to state governments at Rs 400 per dose29 Apr, 2021, 06.29 PM IST
Covaxin phase 3 trial data approved by subject expert committee, shows 77.8 % efficacy22 Jun, 2021, 03.30 PM IST
Bharat Biotech Covaxin Efficacy Data: How effective is the vaccine?04 Mar, 2021, 03.15 PM IST
After Covishield, Bharat Biotech's Covaxin arrives in New Delhi13 Jan, 2021, 10.08 AM IST
Covid-19: Bharat Biotech's nasal vaccine cleared for use06 Sep, 2022, 04.29 PM IST
Phase 3 clinical trial: Bharat Biotech says COVID-19 vaccine shows 81% interim efficacy03 Mar, 2021, 05.53 PM IST
COVID Vaccine: Bharat Biotech's COVAXIN expected to be at least 60% effective, roll-out likely by mid-202122 Nov, 2020, 10.36 PM IST
6 of our other vaccines have already been approved by WHO: Bharat Biotech23 Oct, 2021, 04.44 PM IST
India's Covaxin yet to receive WHO endorsement, govt to push for approval23 May, 2021, 10.19 AM IST
Covid vaccination drive: Bharat Biotech to pay compensation if Covaxin causes side effects16 Jan, 2021, 03.55 PM IST
Bharat Biotech announces interim analysis results of Phase3 trials21 Apr, 2021, 04.06 PM IST